Buscar
01/09/2024
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
Barba, A, López-Vilaró, L, Ferre, M, Majem, M, Martinez-Recio, S, Bell, O, Arranz, MJ, Salazar, J, Sullivan, I. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. Pharmaceutics. 2024; 16(9)DOI:10.3390/pharmaceutics16091121. PMID:39339159. IF:5.500(Q1/1D).
01/09/2024
Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series
Prat, A, Piñol, D, Espadaler, I, Campazas, I, Espinosa, I, Fusté, V, Szafranska, J, Fumagalli, C. Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series
Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
Carrillo-García, J, Hindi, N, Conceicao, M, Sala, MA, Ugalde, A, López-Pousa, A, Bagué, S, Sevilla, I, Vicioso, L, Ramos, R, Martínez-Trufero, J, Mateo, MCG, Cruz, J, Hernández-León, CN, Redondo, A, Mendiola, M, García, JM, Hernández, JE, Alvarez, R, Agra, C, de Juan-Ferré, A, Valverde, C, Cano, JM, de Sande, LM, Pérez-Fidalgo, JA, Lavernia, J, Marcilla, D, Gutiérrez, A, Moura, DS, Martín-Broto, J. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. EUROPEAN JOURNAL OF CANCER. 2024; 209DOI:10.1016/j.ejca.2024.114270. PMID:39142211. IF:7.100(Q1/2D).
01/08/2024
Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
Pasquali, S, Vallacchi, V, Lalli, L, Collini, P, Barisella, M, Romagosa, C, Bague, S, Coindre, JM, Dei Tos, AP, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Lopez-Pousa, A, Grignani, G, Blay, JY, Beveridge, RD, Casiraghi, E, Brich, S, Renne, SL, Bergamaschi, L, Vergani, B, Sbaraglia, M, Casali, PG, Rivoltini, L, Stacchiotti, S, Gronchi, A. Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy. EBioMedicine. 2024; 106DOI:10.1016/j.ebiom.2024.105220. PMID:39018755. IF:10.800(Q1/1D).
01/07/2024
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging
Espinosa, I, D'Angelo, E, Prat, J. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. GYNECOLOGIC ONCOLOGY. 2024; 186DOI:10.1016/j.ygyno.2024.04.008. PMID:38615479. IF:4.100(Q1/1D).